Biocytogen Pharmaceuticals (Beijing) Co., Ltd. have reached an agreement with BeiGene (Beijing) for licensing of Biocyto...
China's CARsgen Therapeutics Holdings, a company focused on innovative CAR T cell therapies for the treatment of hematol...
SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, has announced the CE (Conformit&...
Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...
China-based startup Rona Therapeutics announces the successful completion of $33 million Series A financing to advance p...
Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical ...
One of the largest global studies of its kind, led by The Chinese University of Hong Kong (CUHK)’s Faculty of Medi...
Ascletis Pharma has submitted the marketing authorization application for ritonavir (100 mg film-coated tablet) in the H...
CanSino Biologics has announced that the National Medical Products Administration of China (NMPA) granted approval for t...
The latest research shows that Tai Chi training (an internal Chinese martial art) is conducive to the treatment of Parki...
China's Zhimeng Biopharma, Inc., an innovation-driven biopharmaceutical company focused on the development of innovative...
Hong Kong based UMP Healthcare Holdings Limited has announced the results of a recent service survey, which found that a...
China's JW Therapeutics has received the Investigational New Drug (IND) clearance from the National Medical Products Adm...
China's CStone Pharmaceuticals, a leading biopharmaceutical company focused on the research, development, and commercial...
Some COVID-19 patients develop various and persistent symptoms weeks and months after completely recovering from the inf...
China's Biosion, Inc., and US' Pyxis Oncology have entered into an agreement under which Pyxis Oncology will be granted ...
China's CellOrigin Inc, a biotech company focusing on iPSC-derived immune cell therapies, announced it secured a new rou...
Brii Biosciences has announced that TSB Therapeutics (Beijing), a joint venture majority-owned by the company, is p...
